14
Dec
2026

Jiangsu Kingsley Pharmaceutical Co., Ltd.

Exhibitor at CPHI Middle East 2026 stand H2.D60
About Us

Jiangsu Kingsley Pharmaceutical Co., Ltd. is a Chinese bio-pharmaceutical enterprise specializing in the R&D, production, and commercialization of medicines for aging-related diseases. Established in 1992, Kingsley is the 1st GMP Certified bioproduct enterprise in China. The company has a business portfolio including lyophilized powder injections of biological drugs & chemical drugs, medical devices and health food, among which there are 22 drugs covering 12 therapeutic areas and a diversified product matrix under R&D.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    China
  • On CPHI since:
    2026
  • Certificates:
    2
  • Employees:
    100 - 249
Company types
Biopharmaceutical company
CMO/CDMO
Distributor/Import Export
Generics/Biosimilars Manufacturer
Pharmaceutical company
Primary activities
Biopharmaceutical
Contract Manufacturer
Medical Devices
Nutraceuticals
Pharmaceutical Company (generic finished products)
View company profile
Contact info
  • +86 13951763413
  • Website
  • No. 18, Chaquan Road,, Industrial Park of Environmental Science&Technology,, 214200, Yi Xing, Jiangsu, China
Show contact info Hide contact info
Event information
CPHI Middle East 2026
  • 14 Dec 2026 - 16 Dec 2026
  • Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia
  • Visit us at stand H2.D60

Products Featured at CPHI Middle East 2026

  • Aciclovir for Injection

    Product Aciclovir for Injection

    Advantages: 1.A classic anti-herpesvirus drug with potent activity against herpes simplex virus type 1/2 and varicella-zoster virus. It is the first-line drug, featuring rapid onset of action and precise targeting;
    2.High safety profile, mild adverse reactions, and broad population applicability; q...
  • Amoxicillin Sodium and Sulbactam sodium for Injection

    Product Amoxicillin Sodium and Sulbactam sodium for Injection

    Indications:This product is a combination preparation of Amoxicillin and Sulbactam Sodium. It is indicated for the following infections caused by β-lactamase-producing Staphylococcus, Klebsiella pneumoniae, other Streptococcus, Hemophilus Influenzae, Neisseria gonorrhoeae, Escherichia coli, Proteus species...
  • Azithromycin for Injection

    Product Azithromycin for Injection

    Advantages: 1. 0.125g and 0.25g: unique production in China;2. The flagship product among macrolide antibiotics；
    3. A broad-spectrum antibiotic featuring a unique Trojan horse mechanism and a long post-antibiotic effect (PAE).

    Indications-This product is indicated for the following infec...
  • Dextromethorphan Hydrobromide for Injection

    Product Dextromethorphan Hydrobromide for Injection

    Advantages:1.Extremely few manufacturer domestically and internationally;
    2.Potent antitussive efficacy with rapid clinical onset of action (within 15-30 minutes);
    3.No respiratory depression at therapeutic doses, with a dosage only one-sixth of the oral formulation;
    4.Inhibits abnormal cough refl...
  • Diammonium Glycyrrhizinate for Injection

    Product Diammonium Glycyrrhizinate for Injection

    Advantages:1.China-exclusive and the sole export product;
    2.3rd generation glycyrrhizin preparation with highly efficient extraction of alpha-isomer structure, higher lipophilicity, better targeting property, enhanced hepatic anti-inflammatory effect, and reduced risk of renal pseudoaldosteronism;
    3....